nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ABT-737, a BH3 mimetic, induces glutathione depletion and oxidative stress
|
Howard, Adrienne N. |
|
2009 |
65 |
1 |
p. 41-54 |
artikel |
2 |
A dose escalation and pharmacokinetic study of the biweekly administration of paclitaxel, gemcitabine and oxaliplatin in patients with advanced solid tumors
|
Saridaki, Zacharenia |
|
2009 |
65 |
1 |
p. 121-128 |
artikel |
3 |
A dose-finding and pharmacokinetic study of nedaplatin in elderly patients with advanced non-small cell lung cancer
|
Yamamoto, Noboru |
|
2009 |
65 |
1 |
p. 79-88 |
artikel |
4 |
A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors
|
Muindi, Josephia R. |
|
2009 |
65 |
1 |
p. 33-40 |
artikel |
5 |
A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer
|
Furuse, Junji |
|
2009 |
65 |
1 |
p. 113-120 |
artikel |
6 |
A phase II trial of biweekly oxaliplatin with simplified schedule of 48-h infusion of high-dose 5-fluorouracil and leucorvin for advanced biliary tract carcinoma
|
Chen, Jen-Shi |
|
2009 |
65 |
1 |
p. 151-157 |
artikel |
7 |
Biological reactive intermediates that mediate dacarbazine cytotoxicity
|
Pourahmad, Jalal |
|
2009 |
65 |
1 |
p. 89-96 |
artikel |
8 |
Combination analyses of anti-cancer drugs on human neuroendocrine tumor cell lines
|
Larsson, Dhana E. |
|
2009 |
65 |
1 |
p. 5-12 |
artikel |
9 |
Hepatic portal venous gas in a patient with metastatic non-small cell lung cancer on bevacizumab therapy: a case report and review of the literature
|
Ortega, Jose |
|
2009 |
65 |
1 |
p. 187-190 |
artikel |
10 |
K-ras status in squamous cell anal carcinoma (SCC): it’s time for target-oriented treatment?
|
Zampino, Maria Giulia |
|
2009 |
65 |
1 |
p. 197-199 |
artikel |
11 |
Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors
|
Denlinger, Crystal S. |
|
2009 |
65 |
1 |
p. 97-105 |
artikel |
12 |
Pharmacokinetics of temozolomide administered in combination with O6-benzylguanine in children and adolescents with refractory solid tumors
|
Meany, Holly J. |
|
2009 |
65 |
1 |
p. 137-142 |
artikel |
13 |
Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies
|
Lin, Chia-Chi |
|
2009 |
65 |
1 |
p. 167-175 |
artikel |
14 |
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers
|
Dowlati, Afshin |
|
2009 |
65 |
1 |
p. 73-78 |
artikel |
15 |
Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer
|
Lee, Sung-Ji |
|
2009 |
65 |
1 |
p. 159-166 |
artikel |
16 |
Phase I study of larotaxel administered as a 1-h intravenous infusion every 3 weeks to Japanese patients with advanced solid tumours
|
Yamamoto, Nobuyuki |
|
2009 |
65 |
1 |
p. 129-136 |
artikel |
17 |
PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin
|
Yuan, Zhu |
|
2009 |
65 |
1 |
p. 13-25 |
artikel |
18 |
Preclinical pharmacokinetics and in vitro activity of ON 01910.Na, a novel anti-cancer agent
|
Chun, Amy W. |
|
2009 |
65 |
1 |
p. 177-186 |
artikel |
19 |
Preclinical pharmacokinetics and in vitro metabolism of brivanib (BMS-540215), a potent VEGFR2 inhibitor and its alanine ester prodrug brivanib alaninate
|
Marathe, Punit H. |
|
2009 |
65 |
1 |
p. 55-66 |
artikel |
20 |
Safety and pharmacokinetic trial of docetaxel plus an Astragalus-based herbal formula for non-small cell lung cancer patients
|
Cassileth, Barrie R. |
|
2009 |
65 |
1 |
p. 67-71 |
artikel |
21 |
Successful desensitization with cetuximab after an infusion reaction to panitumumab in patients with metastatic colorectal cancer
|
Saif, Muhammad Wasif |
|
2009 |
65 |
1 |
p. 107-112 |
artikel |
22 |
The polyamine analog PG11047 potentiates the antitumor activity of cisplatin and bevacizumab in preclinical models of lung and prostate cancer
|
Dredge, K. |
|
2009 |
65 |
1 |
p. 191-195 |
artikel |
23 |
The potential of vitamin K3 as an anticancer agent against breast cancer that acts via the mitochondria-related apoptotic pathway
|
Akiyoshi, Takeshi |
|
2009 |
65 |
1 |
p. 143-150 |
artikel |
24 |
UGT1A1 polymorphism and hyperbilirubinemia in a patient who received sorafenib
|
Meza-Junco, Judith |
|
|
65 |
1 |
p. 1-4 |
artikel |
25 |
UGT1A1 polymorphism and hyperbilirubinemia in a patient who received sorafenib
|
Meza-Junco, Judith |
|
2009 |
65 |
1 |
p. 1-4 |
artikel |
26 |
Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck
|
Cho, Byoung Chul |
|
2009 |
65 |
1 |
p. 27-32 |
artikel |